Possible immunotherapeutic potentiation with D-Fraction in prostate cancer cells
<p>Abstract</p> <p>Background</p> <p>Prostate cancer remains the most common malignancy among elderly men and the second leading cause of cancer death in the United States. Although several conventional therapies are currently available, they have a low efficacy and the...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-12-01
|
Series: | Journal of Hematology & Oncology |
Online Access: | http://www.jhoonline.org/content/1/1/25 |